Seaport Therapeutics
Focus: Seaport Therapeutics is a Boston-based neuro-focused biotech company leveraging a proprietary discovery platform to develop treatments in psychiatry and metabolic diseases. The company is in early-stage clinical development with a lean operational footprint.
Profile data last refreshed 17h ago · AI intelligence enriched 3w ago
Open Jobs
9+1 this month
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Should You Work at Seaport Therapeutics?
AI assessmentBest suited for mission-driven scientists willing to accept early-stage risk in exchange for deep platform involvement and neuro-focused science, but not a stable mid-career choice without visibility into funding and headcount plans.
Why Work Here
- Ground-floor opportunity at a platform-driven neuro company with focused therapeutic areas (psychiatry, metabolic diseases) offering early-career scientists meaningful drug discovery exposure
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_2
Clinical Trials (1)
NCT07065240A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Phase 2Help build intelligence for Seaport Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.